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ABSTRACT  The  class of  nonhistone  chromosomal  proteins  that  remains  bound  to  DNA  in 
chromatin  in  the  presence  of  2.5  M  NaCl-5  M  urea  has  proven  refractile  to  biochemical 
analysis.  In order to study its role in chromatin organization, we have  produced  monoclonal 
antibodies that are specific for the  HeLa DNA-protein complex that remains  after extraction 
of chromatin with high salt and urea. The antibody-producing clones were identified with an 
ELISA assay. Of the six clones selected, five were stabilized by limiting dilution. All clones are 
IgG  producers.  None  cross-react  significantly  with  native  DNA,  core  histones,  or the  high- 
mobility  group  nonhistone  proteins.  All  antibodies  are  specific  for  nuclear  or juxtanuclear 
antigens.  Indirect immunofluorescence  shows that three antibodies, which are  nonidentical, 
stain three different nuclear networks. Available evidence indicates that two of these networks 
are the nuclear matrix. A fourth antibody reveals structures reminiscent of chromocenters. A 
fifth antibody, AhNA-I,  binds to interphase HeLa chromatin and specifically decorates  meta- 
phase chromosomes. AhNA-I similarly recognizes rat chromosomes. Each of these monoclonal 
antibodies also reveals a changing pattern of nuclear staining as cells progress through the cell 
cycle. Presumably, this reflects  the rearrangement of the cognate antigens. 
The eucaryotic chromosome contains at least twice as much 
protein  by  mass  as  DNA  and  both  are  complexed  in  a 
structure defined as chromatin. Treatment of either purifed 
nuclei or chromatin by high salt (2.0 M NaC1) removes almost 
all histones and most nonhistone proteins (1-3). The proteins 
remaining  bound  to  DNA  in  chromatin  after  high  ionic 
strength extraction (2  M  NaCI or 2 M  NaC1-5M  urea) are 
nonhistones, and they constitute 5-8% of  the total chromatin 
protein. These are termed residual or tight-binding proteins 
(4-6).  The  tight-binding,  nonhistone  chromatin  proteins 
(TBP) from animal cell nuclei are electrophoretically  complex 
(~200 species, Bhorjee, J. S. and L. Kite, unpublished data), 
and are distributed nonrandomly along the DNA molecule 
(reference 5, reviewed in reference 6). 
Two functions for these proteins have been suggested,  al- 
though no direct evidence exists. Based on the DNA sequence- 
specific association of certain nonhistone proteins with chro- 
matin  DNA,  a  role  in  specific gene  expression  for these 
proteins has been proposed (7-13). It has also been demon- 
strated that some TBPs bind to androgen-receptor (14) and 
progesterone-receptor (15)  complexes.  Thus,  at  least  some 
gene regulatory molecules in eukaryotes may reside in this 
group of chromosomal proteins. A second function may be 
structural. The structural integrity of the nuclear matrix (4, 
16) and the chromosome scaffold (17) seems to rely on the 
presence of such high-ionic strength (2 M NaCI), nonextract- 
able nuclear nonhistone proteins. 
Closer examination of  these proposals by biochemical anal- 
ysis of individual tight-binding nonhistone proteins has not 
been possible for two reasoaas: (a) each is  present in small 
amounts and (b) dissociation of the DNA-protein complex 
requires denaturing solvents that may lead to irreversible loss 
of functions. Therefore, to avoid these problems and to study 
the structure and function of HeLa tight binding chromatin 
proteins, we  have prepared  monoclonal antibodies against 
this group of nonhistone proteins. We present here an initial 
characterization of several HeLa TBP-specific monoclonal 
antibodies and their antigens.  In  addition,  we  use indirect 
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butions of these antigens change dramatically during the cell 
cycle. 
MATERIALS AND  METHODS 
Cell Growth, Chromatin Isolation, and  TBP  Fractiona- 
tion:  HeLa  cells  were  grown  in  suspension cultures in  Joklik-modified 
Eagle's medium (18),  and chromatin was purified from isolated nuclei by 
sedimentation through 60% sucrose as previously described (19). TBPs were 
fractionated from purified chromatin by treatment with 2.5 M NaCI-5 M urea 
followed by sedimentation of the TBP-nucleoprotein complex at 408,000 g for 
24 h as described (5). This TBP-nuclcoprutcin complex was used as an immu- 
nogen. All steps were performed at 4°C and all solutions contained 0.1  mM 
PMSF as protease inhibitor. Where indicated, cells were synchronized by the 
double-thymidine block procedure as described previously (20). 
Immunological Detection  of Proteins by  Electrophoretic 
BIotting:  The TBPs were dissociated from the TBP-nucleoprotein complex, 
as obtained above, by treatment with 2% sodium dodecyi sulfate (SDS),  1% 2- 
mercaptoethanol (BME),  at  room temperature for  30  rain  with occasional 
vortexing. The sample was then dialyzed overnight against Tris-NaCl buffer 
(0.01 M NaCl, 0.0025 M Tris-HCl, pH 7.2)containing 1% SDS-I% BME, and 
centrifuged at 150,000 g for 20 h in Beckman SWS0.1 rotor (Beckman Instru- 
ments, Inc., Spinco Div., Palo Alto, CA) at 20°C, to pellet DNA. Almost all of 
the protein (>99%) was in the supernatant and DNA (>98%) was in the pellet, 
as determined by [~4C]leucine and [3H]thymidine labelin~ respectively.  The 
cytoplasmic proteins were obtained by centrifuging  the postnuclear supernatam 
(19) at 3,000 g for 15 min in Sorvall  SS-34 rotor at 40C. The nuclear matrix 
proteins were obtained by the procedure of Berezney and Coffey (16), except 
for the pretreatment of isolated nuclei with DNase I (100 ~g/l mg DNA) for 30 
min at 22°C  to avoid gel  formation in the high-salt buffer treatment step. 
Various protein samples (TBPs; nuclear matrix; cytoplasmic) were treated with 
1% SDS-I% BME, heated at 90*C for 2 min, and dialyzed against Laemmli 
sample buffer (2 l) before eleetrophoresis. 
The eleetrophoretic transfer and immunological detection of the eleetro- 
blots was carried out essentially as described by Towbin et al. (22). Briefly, the 
proteins were first separated in a  I 1% polyacrylamide SDS-slab gel and trans- 
ferred  eleetrophoretically to a  nitrocellulose membrane sheet using Hoeffer 
"Transhlot" apparatus. The eleetrophoretic blot membrane strips were  incu- 
bated with a twofold dilution of the monoclonal culture supernatant, washed, 
and further incubated with ~2SIqabeled goat anti-mouse IgG (Amersham  Corp., 
Arlington Heights, IL).  The strips were  then washed free  of the unreaeted 
secondary antibody and exposed to Kodak X-Omat AR film in the presence of 
an intensifying screen. 
Plasmacytoma Culture Conditions:  The  nonsecreting,  8-aza- 
guanine-resistant mouse plasmacytoma line SP2/0-AgI4 was grown in high 
glucose Dulbecco's modified Eagle's medium (DME) supplemented with 20% 
agamma horse serum (KC Biologicals), penicillin, and streptomycin. Cultures 
were maintained between l05 and 7 x  105 cells/ml at 37°C in a humid chamber 
containing 5% CO2. 
Immunization and Preparation of Hybridomas:  BkLB/cmice 
(12-16  wk old)  were  immunized by intraperitoneal injection of 0.5  ml of 
immunogen in PBS (100 zg/ml). Animals were boostered at 3-wk intervals by 
i.p.  injection as above. 60-72 h after the sixth injection (into the tail vein), 
dissociated spleen cells were prepared from an immunized animal and were 
fused with  SP2/0  cells  using 50%  polyethylene glycol  (PEG  1500,  Fisher 
Scientific  Co., Pittsburgh, PA) as described by McKearn et al. (23).  Treated 
cells  were  incubated overnight at  370C in  5%  CO2  in  high glucose DME 
containing 20% agamma horse serum. Cells were harvested the following day 
and were  resuspended in high glucose DME containing 20%  agamma horse 
serum,  l  ×  10  -4 M  hypoxanthine, 4  x  10  -v M  aminopterin, 3  x  10  "q M 
thymidine, L-arginine (0.116  g/l), L-glutamine (0.216  g/l), folic acid (0.006  g/ 
l), L-asparaglne (0.036 g/l), sodium bicarbonate (2.0 g/l), and sodium pyruvate 
(0.11 g/l). Cells were distributed in 100-#l aliquots into 400 or more microtiter 
wells and incubated at 37°C in 5% CO2. 5-6 d later, hyhridomas were fed with 
an additional  100 ~tl of the above-described medium lacking hypoxanthine, 
aminopterin, and thymidine. A similar protocol using Freund's adjuvant gave 
a similar frequency of positive hyhridomas. 
Screening of Hybridomas and Preparation of Monoclonal 
Antibodies:  Positive hybridomas were detected by an ELISA assay (24). 
The high salt-urea insoluble DNA-protein complex prepared as described above 
was diluted to 10-20 zg protein/ml PBS and distributed in 50-1zl aliquots into 
polyvinylchloride microtiter wells. After 2 h at 20°C, each well was emptied, 
washed four times with PBS, filled with 100/~l of 3% BSA, 0. 1% sodium azide 
in PBS, sealed with tape, and stored at 4°C for up to 2 d before use. Polyvinyl- 
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chloride mierotiter plates coated with immunogen  were washed in PBS, washed 
once for 30 min in 3.0% BSA in PBS, filled with 50 ~1 of hybridoma culture 
supernatant, and incubated for 2 h at 20°C. Wells were then washed five times 
with solution A (PBS  +  0.1% Tween-70) and filled with  100 ~! of a  1:200 
dilution of/3-galactosidase-conjugated F(ab')2 sheep or rabbit anti-mouse IgG 
(H & L) (Bethesda Research Laboratories, Gaithersbmg, MD) in solution A. 
After 2 h at 20"C, each well was washed five times in solution A and filled with 
100 #1 of 5-bromo-4-chloro-indolyl-/~-D-galactoside  in PBS (100 ~g/ml). Alter 
30-60  min at  20"C,  a  blue color developed in wells  that received culture 
supernatants containing antibody specific for an antigen in the DNA-protein 
complex. For ELISA assays using PVC plates coated with histones or the high 
mobility group proteins (HMGs), the procedure described above was followed. 
Indirect Immunofluorescence:  An aliquot (1 ml) of  actively divid- 
ing or synchronized HeLa cells was harvested, washed, and suspended at the 
same concentration in PBS. One or two drops of washed cells were placed on 
poly-L-lysine-precoated  slides,  and  the cells  were  fixed in  periodate-lysine- 
paraformaldehyde as described by McLean and Nakane (25). Fixed cells were 
incubated for 45 min with  100 ul of hybridoma culture supernatant, washed 
for 45 min in three changes of PBS, and then incubated for45 min with a 1:50 
dilution in PBS of fluorescein isothiocyanate-conjugated goat anti-mouse lgG 
(Tago).  After a final 45-min wash in three changes of PBS, the preparations 
were viewed microscopically and fluorescence was recorded with Kodak Ek- 
tachrome 400 film. 
RESULTS 
Preparation of Immunogen and Generation of 
Hybridoma Clones 
The DNA-protein complex that remains after extraction of 
HeLa chromatin with 2.5 M NaC1-5 M urea was used as an 
immunogen to raise monoclonal antibodies. Some physical 
and chemical properties of this group of high-affinity DNA- 
binding nonhistone proteins have been previously described. 
For example, the TBPs consititue 5-8% of  the total chromatin 
protein, are nonhistones, are not related to the proteins of the 
heterogeneous ribonucleoprotein particles, and are distributed 
asymmetrically along the DNA molecule (5). 
This nucleoprotein complex is a weak immunogen. In two 
separate fusions, not more than 2% of the hybridomas se- 
creted antibodies that reacted with the respective antigens as 
determined by the ELISA assay (24). At least five injections 
were necessary before a weak positive antibody response could 
be  detected  in  the  immune  sera.  We  have  identified  six 
positive clones,  and  five of these  have been  stabilized by 
several subclonings, thus assuring the monoclonal nature of 
each of the stabilized clones. 
Characterization of the Monoclonal Antibodies 
We examined five stabilized hybridoma lines for their an- 
tigen specificity by using the ELISA assay (see Materials and 
Methods). All five hybridomas are IgG producers. Table I 
shows that the antigen-antibody binding reaction is specific 
for the 2.5 M  NaC1-5 M  urea stable nucleoprotein complex 
(TBP). We have  numbered the  antibody-producing clones 
with the prefix AhNA for anti-human nuclear antigen. Clones 
AhNA-4  and  AhNA-5  give  a  strong  ELISA  reaction and 
AhNA-2 gives the weakest response. All antibodies are reac- 
tive with the native complex of HeLa TBP (column 3). This 
reactivity remains even after digestion of the native complex 
with DNase I (column 9). HeLa double-stranded DNA does 
not react with these antibodies. The weak reactions of HeLa 
single-stranded DNA and HeLa HMGs occur only when these 
components are present in the assay in amounts that are far 
greater than  are  found in  the  native  complex.  The  weak 
reaction of some antibodies with preparations of HeLa cyto- 
plasm is expected to result from dispersal of some nuclear 
antigens into the cytoplasm arising from a minimum number TABLE  I 
ELISA Assay of Subcellular  Fractions 
Antigen source 
HeLa TBP  DNase I sensitiv- 
(native  HeLa  HeLa  HeLa  ity of the TBP 
Clone  Class*  complex)  dsDNA  ssDNA  HMGs  HeLa CP  HeLa NM  complex* 
AhNA1  IgG  3+  -  ±  -  ±  -  - 
AhNA2  IgG  3+  -  ±  .... 
AhNA3  IgG  3+  -  ±  -  -  2+  - 
AhNA4  IgG  4+  -  ±  ±  ±  2+  - 
AhNA5  IgG  4+  -  ±  ±  ±  ±  - 
AhNA6  NT  3+  NT  NT  NT  NT  NT  NT 
* Determined by Ouchterlony assay. 
+, Indicates the rate of reaction; for example, 4+ wells positive in 20 min; 3+ in 45 min; 2+ in 90 min. The amount of antigen per well within a column was 
kept constant. Also, in assays  for TBP, HMGs, CP, and NM ~0.75/~g of total protein was added per well. 
_+, Slightly above background. 
NT, Not tested. 
-, Background, no color. 
* The TBP complex was treated with 100/~g pancreatic DNAase I/mg DNA at 37"C for up to 4 h. Controls with  DNAase alone used as an antigen showed no 
cross reaction; and incubation of the TBP-complex antigens at 37"C for 4 h did not diminish the reaction. 
HMG,  High mobility group nuclear proteins prepared as 5% perchloric acid extracts from which  histone H1  has been selectively removed by differential 
acetone precipitation (43). The presence or absence of H1 in the HMG preparations had no effect on the ELISA reaction. 
NM, Nuclear protein maxtrix obtained by published methods.(16). 
CP, Cytoplasmic proteins. 
TABLE  II 
Species Specificity and the Cellular Distribution of the HeLa DNA-TBP Chromatin Antigen as Determined by Indirect 
Immunofluorescence 
Clone 
Cell type 
Cellular Iocaliza-  Rat 
tion  HeLa  muscle  Distribution Pattern  Pattern frequency* 
AhNA1 
AhNA2 
AhNA3 
AhNA4 
AhNA5 
AhNA6 
Nuclear  +  +  Metaphase chromosomes;  punc-  >90%  punctate  (Fig.  1,  bottom 
tate in interphase cells  right); 5-10% chromosomes 
Nuclear  +  -  Ranges  from  one  large  spot  or  60-65%  crescent-shaped;  20- 
crescent-shaped  to  granular  30%  large spot;  5% weak to  no 
(chromocenter?)  reaction 
Nuclear  +  -  Matrixlike pattern  >70%  matrixlike;  remainder 
threadlike to weak reaction 
Nuclear  +  +  Matrixlike pattern  80%  matrixlike;  remainder weak 
to no reaction 
Nuclear  +  _.+  Mostly matrixpattern  70-75%  matrixlike  (similar  to 
AhNA3) 
Nuclear  +  NT  Patchy  80% patchy 
20% weak reaction 
NT, not tested. 
-, faint fluorescence. 
* In all cases a minimum of 200 cells were observed. 
of mitotic cells in the unsynchronously growing population 
or synthesis of the antigen in the cytoplasm. The reaction of 
two of these antibodies with HeLa nuclear matrix proteins is 
analyzed later in this paper. 
Cellular Localization and Distribution Pattern of 
the Antigens by Indirect Immunofluorescence 
Table II lists the immunofluorescent staining properties of 
antibodies produced by the five stabilized clones and by one 
clone (AhNA-6) that has not been stabilized. Two mammalian 
cell lines (HeLa and L8  rat skeletal  muscle) were tested by 
immunofluorescence.  Fig.  1  shows the  immunofluorescent 
staining patterns summarized by Table II. The frequencies of 
the  immunofluorescent  patterns  for various  antibodies  are 
also given in Table II. Clearly, the interphase cells display the 
dominant staining patterns seen in Fig.  1. 
Comparative phase contrast (not shown) and immunoflu- 
orescence micrographs (Fig.  1) indicate that the cognate an- 
tigens of these antibodies are arranged in distinctive patterns 
within the nucleus. Although some antibodies revealed stain- 
ing juxtaposed to the nuclear membrane (e.g., AhNA 2, Fig. 
1), as far as could be discerned, no cytoplasmic fluorescence 
was evident. Nor is the nuclear staining so diffuse as found 
for heterogeneous nuclear RNA-ribonucleoprotein antigens 
(26).  The  staining  patterns  are  always  highly reproducible 
within and between experiments. 
The most readily interpretable staining is the specific dec- 
oration of metaphase chromosomes by AhNA- 1 (Fig.  1). This 
antigen is present in two cell types and species (HeLa cells 
and rat skeletal myoblasts) since both cell types show identical 
patterns  of  staining  of  metaphase  chromosomes  (rat  not 
shown). No other monoclonal antibodies tested stain mitotic 
chromosomes in this pattern (see Fig. 3). 
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antibodies to the HeLa TBPs. Bars, 10 #m. 
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electro-blot analysis of the bind- 
ing of  the  monoclonal  antibody 
AhNA-4  to  HeLa  cytoplasmic 
(lane A), TBP (lane B), and nuclear 
matrix (lane C) proteins. For each 
sample,  150 #g total protein was 
separated  in  11%  polyacrylam- 
ide-SDS gel slab, transferred  elec- 
trophoretically  to  nitrocellulose, 
incubated  with  the  antibodies, 
and  processed  for  autoradiogra- 
phy as described under Methods. 
Exposure was for 18 h in the pres- 
ence  of  an  intensifying  screen. 
Arrowhead  indicates  molecular 
weight x  10  -3. 
A  second  staining  pattern  is  shown  by AhNA-2,  which 
binds  to  a  single  spot  within  the  nucleus or appears  in  a 
crescent shape beneath  the  nuclear envelope (Fig.  1).  It is 
reminiscent of  the chromocenter of  Drosophila chromosomes 
(27). Whether this antibody detects a chromocenter or heter- 
ochromatin-associated protein(s) near the inner nuclear mem- 
brane in HeLa cells remains to be established. Note that this 
spot is  not coincident with nucleoli, which appear as dark 
bodies in phase contrast micrographs (not shown). 
Monoclonal antibodies AhNA-3, 4, and 5 reveal somewhat 
similar  matrixlike  structures  within  the  nucleus  (Fig.  1). 
AhNA-3 and 4 give positive ELISA reactions with prepara- 
tions of HeLa nuclear matrix (Table I). They also detect the 
same small set of TBP and nuclear matrix proteins on "West- 
ern" gels (Fig. 2; gel for AhNA-3 gave a similar blot, pattern 
not shown). The same three polypeptides in TBP and nuclear 
matrix preparations are recognized by AhNA-4. The predom- 
inant polypeptide is  ~70,000 daltons (Fig.  2). Three major 
polypeptides of  the rat liver nuclear matrix are between 60,000 
and  70,000  daltons  (16).  These antibodies  may detect an 
antigen that is shared by a  few polypeptides. Alternatively, 
they may detect different antigens on the same set of polypep- 
tides. The fact that AhNA 3 and 4 react with nuclear matrix 
antigens in ELISA (Table I) and "Western" blots (Fig. 2) raises 
the possibility that the observed staining in Fig. l corresponds 
to  the  nuclear  matrix.  Monoclonal  antibody  AhNA-5  is 
clearly different form AhNA-3  and 4.  It does not form an 
immune complex with either TBP or nuclear matrix proteins 
on "Western" blots or TBP solubilized by any of our current 
methods. Thus, we have not determined the molecular weight 
of its antigen. The matrixlike pattern that AhNA-5 shows  is 
always more delicate than that made apparent by AhNA-3 
and  4  (Fig.  1).  Thus,  two different matrixlike patterns are 
made visible by these antibodies. 
The  unusual  immunolluorescent configurations  are  not 
artifacts of  the formaldehyde cell fixation procedure, as shown 
by the following.  First, an alternate fixation procedure using 
acetone gives identical immunoflu0rescent patterns. Second, 
the AhNA-1  specific staining of metaphase chromosomes is 
undisturbed by fixation, thereby constituting a strong control 
for chromatin staining. Furthermore, the absence of staining 
by secondary antibody alone also indicates that these mono- 
clonal antibodies are specific for HeLa chromatin nonhistone 
proteins. 
Finally, AhNA-6 reveals a "patchy" nuclear distribution of 
its antigen. This pattern may be that of a  heterochromatin- 
specific polypeptide. Its immunofluorescence pattern is defi- 
nitely not like the matrixlike pattern given by AhNA-3, 4, or 
5.  Although  many  cells  have  been  examined  by  indirect 
staining with AhNA-6,  none have threadlike, criss-crossing 
structures shown by AhNA-3, 4, or 5. This antibody has not 
been extensively studied because the hybridoma line has not 
yet been stabilized. 
Cell Cycle and Nuclear Immunofluorescence 
Physical and chemical alterations in  chromatin structure 
are known to occur at different stages of  the cell cycle in HeLa 
(20,  28,  29).  Cytological evidence, using the  fluorochrome 
quinacrine, suggests a continuous chromosome cycle through- 
out interphase in human (30) and mouse (31) cells. In order 
to explore the relationship between chromatin organization 
and  the cell cycle, we  have used three of the  monoclonal 
antibodies to determine whether the structural organization 
of their antigens within the nucleus changes as HeLa cells 
progress through the cell cycle. 
Fig.  3  illustrates that the organization of the antigens of 
AhNA-I,  2,  and  3  changes  dramatically  as  cells  progress 
through the cell cycle. Although these antibodies reveal dis- 
tinctly different patterns, one common feature observed is the 
fluorescent patterns that cover the entire cell during mitosis, 
for example, panels for AhNA-2 and 3 in Fig. 3. Because the 
nuclear envelope breaks down at metaphase, one should not 
be surprised to find that nucleoplasmic proteins are released 
into the cytoplasm at this stage. The diffuse staining is not an 
artifact because AhNA-1 shows localized fluorescence at mi- 
tosis.  We interpret the staining pattern of AhNA-2 and 3 at 
mitosis in the Discussion. In the following, we note particular 
features revealed by AhNA-1, 2, and 3. 
Fig.  3 (top panel) shows the immunofluorescent patterns 
obtained with AhNA-1. Cells in G 1 have a distinctly granular 
pattern throughout the  nucleus.  At mitosis,  fluorescence is 
highly localized in patterns that suggest condensed chromo- 
somes which reverses to a granular pattern again in G2 (see 
also Fig. 1). We interpret these results to mean that the antigen 
of AhNA-1 is bound to both interphase chromatin and con- 
densed chromosomes. 
Monoclonal antibody AhNA-2 recognizes a  tight-binding 
protein which is regionalized in the nucleus. G1  stage cells 
show a single, circular structure which often has the appear- 
ance of a  stack  of carefully coiled threads (Fig.  3,  middle 
panel). In some instances, these threads radiate outwardly to 
lie beneath the nuclear envelope. At mitosis, the pattern is 
granular, covering the entire cell,  and in G2 cells,  one sees 
the return of the G l-like bright fluorescent center within the 
nucleus. This staining pattern is highly reproducible. Between 
60 and 80% of cells in the synchronized population show the 
characteristic bright spotlike fluorescence of G 1 and G2 cells. 
Although we cannot yet confirm this inference, the immu- 
nofluorescence pattern of AhNA-2 suggests that its antigen is 
a part of heterochromatin and that the dense bright, coiled 
BHORJEE ET AL.  Nuclear Structural Rearrangements  during the Cell Cycle  393 FICURE 3  Changing patterns  of nuclear distribution of the cognate  antigens  as  revealed  by  indirect immunofluorescence of 
synchronized HeLa  cells treated  with monocIonal antibodies: AhNA-1  (top  panel),  AhNA-2 (middle  panel),  AhNA-3 (bottom 
panel).  Synchronized cells were harvested  at 5 h (5), 8 h (G2), 10 h (M), and 13 h (early Cl) after release from the thymidine 
block (20). Note: the micrograph for AhNA2-G1 has been spliced to juxtapose two cells in the same view. 
structure is a  "chromocenter," as defined by Natarajan and 
Gropp (32).  We  are  unaware  of any  immunofluorescence 
studies that have directly visualized a chromocenter of  human 
cells. However, earlier cytological studies using Feulgen stain- 
ing and fluorochrome dyes suggested that chromocenters are 
formed by the fusion of constitutive heterochromatin in the 
mouse  (32,  33).  A  disperse,  faintly  quinacrine  fluorescent 
pattern in late G I  to bright fluorescent granular pattern in 
late  G2  and  prophase  of  constitutive  heterochromatin 
(=chromocenters) in  HeLa and mouse fibroblast nuclei has 
been shown to occur as cells progress through the cell cycle 
(30, 31). Furthermore, the number and size ofchromocenters 
seem to vary with the cell cycle stage, being an average of 13 
chromocenters per nucleus in late G1  to  35 chromocenters 
per nucleus in late G2 to prophase in the mouse (31).  The 
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sequence of the bright spotlike immunofluorescence in G2 to 
granular pattern in M and return to dense bright structure in 
G1 for the AhNA-2 antigen  (Fig.  3,  middle panel) suggests 
possible  alterations  in  the  functional  states  of constitutive 
heterochromatin, i.e., the chromocenter, if, indeed, this chro- 
matin arrangement can be equated with the quinacrine stain- 
ing appearance of chromocenters (30-32). 
Fig.  3  (bottom  panel)  illustrates  the  staining  pattern  of 
AhNA-3. In both GI and G2 cells a filamentous, matrixlike 
pattern is seen in the nucleus (see also Fig.  1). This pattern is 
reproducible and is displayed by 70% or more cells within an 
unsynchronized population (Table II). Staining of the cyto- 
plasm does not occur in G 1 or G2 cells.  In contrast, cells in 
mitosis show a diffuse, but slightly granular, pattern of fluo- 
rescence that includes the entire cell. As noted above and in the Discussion, the antigen of  AhNA-3 may be released within 
the cytoplasm when the nuclear envelope breaks down. 
We  note  here  as  a  word  of caution  that  S-phase  cells 
obtained by the double-thymidine block synchronization pro- 
cedure displayed an abnormal diffuse fluorescence over the 
total cell, regardless of the antibody used. This may be due to 
the known cytotoxic effects of the high thymidine concentra- 
tions used for induction of cell synchrony, which have been 
shown to cause reversible unbalanced growth, abnormal cell 
metabolism, and nuclear damage (34-37). 
DISCUSSION 
Only a  few studies have used monoclonal antibodies as re- 
agents to identify and survey the spatial distribution of chro- 
mosomal proteins (38, 39, 41, 42, 44). Our study differs from 
the previous ones in two ways. First, we have focussed specif- 
icaUy on chromatin-associated proteins that remain bound in 
a DNA-protein complex in the presence of 2.5 M NaCI-5 M 
urea. The significance of these proteins was discussed in the 
Introduction. Second, we have examined the subcellular lo- 
calization of these antigens throughout the cell cycle. 
The antigen identified by AhNA- 1 is clearly associated with 
chromatin. The entire metaphase chromosome is visualized 
by  immunofluorescent staining  with  AhNA-1.  This  is  in 
contrast to regional staining, i.e. staining of only the termini, 
as observed by Will and Bautz (27) who used a polyclonal 
antiserum specific for heterochromatin. The cognate antigen 
of AhNA-1  is organized in the chromosome in a way that 
makes it readily accessible  to the antibody. This antigen is 
unlike  the  one  identified by Turner (38),  which  becomes 
accessible  to the antibody only after salt washing of nuclear 
preparations. AhNA-1  does not cross-react with HeLa core 
histones.  Therefore,  the  even  distribution  of fluorescence 
along the metaphase chromosome does not result from reac- 
tion of the antibody with core histones. The granular nuclear 
staining in other cell cycle stages suggests that this antigen is 
present  in  chromatin  throughout the  cell cycle.  We  have 
shown that the antigen is not DNA, core histories,  or HMG 
proteins (Table I). Thus, it appears that a new component of 
chromatin has been identified. This antigen is also present in 
rat chromatin. 
Other workers have shown that antigens present in total 
nonhistone protein preparations are widely distributed along 
the entire length of  individual polytene chromosomes (40). In 
one case, a cognate antigen of a monoclonal antibody that is 
specific for a nonhistone protein is known to be localized in 
regions of active or potentially active genes (41). The antigen 
(AhNA- 1) we identify may similarly be localized in active (or 
inactive) gene regions,  but  we cannot test this  directly by 
immunofluorescence methods because of cytological limita- 
tions inherent to nonpolytene chromosomes. Another alter- 
native that we hope to test is that this antigen is part of the 
chromosome scaffold (17). 
The pattern of immunofluorescence given by AhNA-2 and 
AhNA-3  is  apparently random  in  mitotic cells.  This may 
mean either that the antigen is released from tight complexes 
with  DNA during mitosis,  or that it remains associated at 
only a few regions of each chromosome and these regions are 
distributed randomly in chromosomes at mitosis. We believe 
the first possibility is more likely because the area of diffuse 
staining is quite large, covering the entire cell. 
The antigen identified by AhNA-3 appears to be organized 
in  the  nucleus in  a  way different from the  two discussed 
above. Its organization during GI and G2 resembles that of 
a nuclear matrix. In addition, preparations of nuclear matrix 
contain the cognate antigens of AhNA 3 and AhNA 4. It is 
of  interest to note that this structure disappears during mitosis, 
a period during which the breakdown of the nuclear envelope 
and presumably the nuclear matrix occurs. By early G 1 the 
structure reappears. Apparently, therefore, the antigen is not 
bound to chromosomes at mitosis even though it clearly is a 
component of interphase chromatin. These results strongly 
suggest that the matrixlike structures visualized by antibodies 
AhNA-3  and AhNA-4  (Figs.  1 and  3)  may constitute the 
nuclear matrix. 
The contemporary view of  chromosome structure and func- 
tion  is  dominated  by  our  considerable  knowledge  of the 
biochemical  properties  of histones  and  the  high-mobility 
group of nonhistone proteins. This is largely because these 
proteins are abundant  and can be isolated in  native form. 
Furthermore, well defined functional assays are available for 
analysis of histories and  HMG  proteins.  Bulk  nonhistone 
chromosomal proteins are also thought to have important 
regulatory and structural roles. However, the regulatory pro- 
teins  among  these  are  probably present  in  much  smaller 
amounts, and an almost total absence of suitable functional 
assays makes them quite refractory to conventional biochem- 
ical investigation. Thus, the immunological approach using 
monoclonal antibodies that we and others (38,  39,  41, 42) 
have begun will provide an effective method for accessing the 
functions of this important class  of chromosomal proteins. 
Indeed, our use of such antibodies to study changes in the 
distribution of specific nuclear antigens as HeLa cells traverse 
the cell cycle clearly indicates the advantage of the immuno- 
logical approach. 
This work was supported by National Institutes of Health (N.I.H.) 
grant GM 27236 to J. S. Bhorjee and N.I.H. grant GM 30211 to S. 
L. Barclay. 
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